Indication
Right Heart Failure
3 clinical trials
4 products
1 drug
Clinical trial
Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation: A Randomized, Double-blind, Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Product
Normal salineClinical trial
Repurposing Valsartan May Protect Against Pulmonary HypertensionStatus: Recruiting, Estimated PCD: 2027-07-01
Product
ValsartanDrug
VarlilumabClinical trial
Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary HypertensionStatus: Completed, Estimated PCD: 2023-07-11
Product
Famotidine